• Explore /
  • Poster
  • / Real-world use of pemigatinib (pemi) for cholangiocarcinoma (CCA) among racial and ethnic minorities in the United States.

Real-world use of pemigatinib (pemi) for cholangiocarcinoma (CCA) among racial and ethnic minorities in the United States.

Abstract Video & Slides Poster

Authors

null

Richard D. Kim

Moffitt Cancer Center, Tampa, FL

Richard D. Kim , Cherrishe Brown-Bickerstaff , Angele Kotomale , Michael A. Rodriguez , Bruce A. Feinberg , Sarah Gordon , Kristin M. Zimmerman Savill , Haobo Ren , Michael Blecker , Kim Saverno

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Patient-Reported Outcomes and Real-World Evidence

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 461)

DOI

10.1200/JCO.2024.42.3_suppl.461

Abstract #

461

Poster Bd #

B6

Abstract Disclosures

Similar Posters

Poster

2021 Gastrointestinal Cancers Symposium

Targeted therapies in cholangiocarcinoma: Assessment of US oncologist practice patterns.

Targeted therapies in cholangiocarcinoma: Assessment of US oncologist practice patterns.

First Author: Kinjal Parikh

First Author: Tanios S. Bekaii-Saab

First Author: Mitesh J. Borad

First Author: Milind M. Javle